Definition for cosmetics:“Cosmetic” means any natural or synthetic substance or preparation intended to be used, or capable or purported or claimed to be capable of being used, on the various external parts of the human body (including epidermis, hair system,nails, lips and external genital organs) or the teeth and the mucous membranes of the oral cavity for the exclusive or main purpose of cleaning, perfuming or protecting them, or of keeping them in good condition, or of changing or modifying their appearance, or correcting body odors”.
Cosmetic Evaluation Sub Committee (CESC)
Cosmetic dossier acceptance day is every Wednesday of the week from 9.00am to 3.30pm.
OBJECTIVE OF REGISTRATION
Cosmetic product registration can be categorized as,

First step: Obtain the acknowledgment letter from the Manufacturing Division of the NMRA by visiting on Thursday. This letter is required for the ISO 22716 inspection of your manufacturing site to be conducted by a SLAB-accredited ISO inspection body.
Once got the ISO22716:2007 Certification for the facility can proceed with the product registration.
Supportive documents for product label claims (For both local and imported products)
Product dossier should contain all supportive scientific evidence/clinical studies for label claims.
Claims such as ‘dermatologically tested for skin irritancy and allergy’, ‘ophthalmologically tested’, ‘revitalize’, ‘rejuvenate’, and SPF value are not limited to those claims listed above.
Applicable timelines for cosmetic dossier evaluation are as follows:
If the dossier undergoes external evaluation, the applicable evaluation timeline may be extended accordingly.


For locally manufactured cosmetics:
First step: Obtaining the ISO 22716:2007certificate for the cosmetic manufacturing facility is compulsory for all local manufacturers.
Prior to obtain the ISO 22716:2007 certification, local manufacturer need to obtain the acknowledgment letter from the Manufacturing Regulatory Division of NMRA by visiting on Thursday(Contact Manufacturing Regulatory Division for further information). This acknowledgement letter is required for the ISO 22716:2007 inspection of your manufacturing site to be conducted by a SLAB-accredited ISO inspection body.
Once got the ISO22716:2007 certification for the manufacturing facility can proceed with the product registration.
For imported cosmetics:
A valid ISO 22716:2007 certificate for the cosmetic manufacturing facility, or a valid GMP certificate issued by the regulatory authority of the country of origin of the product, should be submitted.
Licensing of Local Manufacturing facilities
The process applies for local manufacturing sites who intended to get marketing authorization for their products in Sri Lanka. The procedure includes a desk review of essential documents including the site master file and several GMP Inspections.
A local manufacturer who wants to register products in Sri Lanka needs to furnish applications regarding his manufacturing facilities. A separate application needs to be submitted to each manufacturing site.
Application has to be submitted online via NMRA’s web portal eNMRA which requires uploading of essential information and documents to enable a desk review and GMP Inspections.
The NMRA Act, No. 5 of 2015 (section 51) & regulations 26 to 30 of part II of medicines regulations pronounce the legal requirements.
After these procedures, an approved Local manufacturer can submit application for formulation approvals.
After obtaining the formulation approval and GMP approval for commercial manufacturing of the facility, local manufacturer can apply for the product registration. After that, local manufacturer can apply for the manufacturing license.
Site Master Files are submissions to NMRA used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of Medicines, Medical Devices, Borderline products and cosmetics.
Good manufacturing practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization.
The National Medicines Regulatory Authority Act No. 5 of 2015 interprets GMP guidelines as ‘good manufacturing guidelines issued by the World Health Organization’. As such, the National Medicines Regulatory Authority (NMRA) adopts the WHO GMP guidelines along with its subsequent updates for the purpose of regulation of pharmaceutical manufacture. The manufacturers are expected to adhere to the Good Manufacturing Practices throughout their activities.
Pharmaceutical manufacturers who intend to apply for marketing authorization in Sri Lanka may be subjected to one or several GMP inspections prior to their site approvals.
GMP Guidelines available on WHO website:
WHO good manufacturing practices for pharmaceutical products: main principles:
https://www.who.int/medicines/areas/quality_safety/quality_assurance/TRS986annex2.pdf?ua=1
WHO good manufacturing practices for sterile pharmaceutical products:
WHO good manufacturing practices for biological products:
https://www.who.int/publications/m/item/annex-2-WHO-gmp-for-biological-products.
Guideline on Approval of an Overseas Manufacturing Plant of Medicines
The Advertising Committee of the NMRA regulates advertisements - printed and electronic material - related to medicines, devices, borderline products and cosmetics to ensure such advertisements are ethical, accurate and appropriate.
Advertisement includes any representation by any means whatsoever, for the purpose of promoting directly or indirectly the manufacture, sale or disposal of any medicine medical device, borderline product or cosmetic.
Guidelines for registration of cosmetics in Sri Lanka